{"id":754395,"date":"2023-05-03T11:40:32","date_gmt":"2023-05-03T15:40:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/"},"modified":"2023-05-03T11:40:32","modified_gmt":"2023-05-03T15:40:32","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/","title":{"rendered":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BALA CYNWYD, Pa., May  03, 2023  (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rjDKUP1avnEkN6leuwx_yPSkRSsEpDlSlzmFZAKt8HsutzLwzEX_ZlskuDYLP8NQKPR0JBp356yS_F0c4twRN2Hds6-5ZhB_dw29R_RTry4=\" rel=\"nofollow noopener\" target=\"_blank\">jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pimA2aYdubW-3-VzmtVDbrGkZ8h5WlXi3ahmOvt784hy18d_Eb-SMgMVyhgo4gQ-5PjbmtAE15tyxFwMb5CJJDw7vqUe3tJW1tBla0KimAaTMkAz4JzwBXXaXfuBkIjq\" rel=\"nofollow noopener\" target=\"_blank\">mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n<p>\n        <strong>Ruth\u2019s Inc. (Nasdaq \u2013 RUTH)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Ruth\u2019s will be acquired by Darden Restaurants, Inc. (\u201cDarden\u201d) (NYSE &#8211; DRI). Ruth\u2019s shareholders will receive $21.50 in cash for each share of Ruth\u2019s they own for a total equity value of approximately $715 million. The investigation concerns whether the Ruth\u2019s Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Darden is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3poclcBJcWowrk35frAs2fJpJFI5JCLr600QttWFJ0RWJqnr46tw5LK3faTW9Ji-c5pSrCuNNjGTaw5OptfzDL2-0tqwPtG9LGFAJ_HYzd6I7CAtKRmlZ24sadi2BSJVJ4_CFpbucLFyKy5zz-hvsnySE7gp8yo6XUt0tujOnLBGNqUEAJjZUKcCeZD4cJO4\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/ruths-inc-nasdaq-ruth\/<\/a>.<\/p>\n<p>\n        <strong>Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, Magenta will merge with Dianthus Therapeutics, Inc. (\u201cDianthus\u201d). Pre-merger Dianthus stockholders are expected to own approximately 78.7% of the combined company and pre-merger Magenta stockholders are expected to own approximately 21.3% of the combined company. Immediately prior to the closing of the proposed merger, Magenta stockholders will be issued contingent value rights representing the right to receive certain payments from proceeds received by the combined company, if any, related to pre-transaction legacy assets. The investigation concerns whether the Magenta Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of the Company\u2019s shareholders in the combined company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3poclcBJcWowrk35frAs2fJpJFI5JCLr600QttWFJ0Rx2bOzEQ9tWjKxWtbQ04s1irBfsbIy5JMGUVPNCpqKan2_nZqwuQ2DrBfj4YBu4l47f4LWbsCiwpdL_8KFJ4RoZ3R0x9ueVxavD74v2gz685rVhUQ3iUez7lkErgCu_MP5WtlJwRPk53ui2FER00aU4q0C23YQCumP49WruHLNMMeMlLoGWDLNDsPToePVFm8=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/magenta-therapeutics-inc-nasdaq-mgta\/<\/a>.<\/p>\n<p>\n        <strong>BELLUS Health Inc (Nasdaq \u2013 BLU)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, BELLUS will be acquired by GSK Plc (NYSE &#8211; GSK). BELLUS shareholders will receive $14.75 cash for each BELLUS common share, for a total equity value of approximately $2.0 billion. The investigation concerns whether the BELLUS Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether GSK Plc is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3poclcBJcWowrk35frAs2fJpJFI5JCLr600QttWFJ0Ry_88mbBjf-Ena4kuA8Ee2KeR-U8c4-I8oUT4FMGrDOm376Qdo_Xk75GcSwL1GMK67PxHJqJQzyqVMD4BcWFLPogDzsji2KIGjVqmd6j7jnkmcyZCPbxEiRKZ0600K_3KeNXyAwmPYEID0YEnr0fpKdDNlAtTvIAiihpkDMbEHiw==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/bellus-health-inc-nasdaq-blu\/<\/a>.<\/p>\n<p>\n        <strong>Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Prometheus will be acquired by Merck (NYSE &#8211; MRK). Prometheus shareholders will receive $200.00 cash for each Prometheus common share, for a total equity value of approximately $10.8 billion. The investigation concerns whether the Prometheus Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Merck is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3poclcBJcWowrk35frAs2fJpJFI5JCLr600QttWFJ0Q9Ig57tOZ-OSc5lJGGewZdyXjSvvNj-NfRrZ5CYD_WOBqdgK2n74PzRowjObVTm6qynfczJo7vzZPpaD6Syov5h4kFsH_ME1e4bcPswjCp3nBywB_jbEc4LB9rF-CKHL5J5TJaQ3UiM83uaSPgt9MsLUxmTZ8b11ZSQ5Yy9ZAUtFvdG6LOA2oIRhbtiInlWyw=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/prometheus-biosciences-inc-nasdaq-rxdx\/<\/a>.<\/p>\n<p>Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTFlYmQxY2YtZjJlYy00NjQ1LTllOTQtZjk3ZWNjYzM2MzllLTExOTk4MzE=\/tiny\/Brodsky-Smith-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BALA CYNWYD, Pa., May 03, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Ruth\u2019s Inc. (Nasdaq \u2013 RUTH) Under the terms of the agreement, Ruth\u2019s will be acquired by Darden Restaurants, Inc. (\u201cDarden\u201d) (NYSE &#8211; DRI). Ruth\u2019s shareholders will receive $21.50 in cash for each share of Ruth\u2019s they own for a total equity value of approximately $715 million. The investigation concerns whether the Ruth\u2019s Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Darden is paying too little &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-754395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., May 03, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Ruth\u2019s Inc. (Nasdaq \u2013 RUTH) Under the terms of the agreement, Ruth\u2019s will be acquired by Darden Restaurants, Inc. (\u201cDarden\u201d) (NYSE &#8211; DRI). Ruth\u2019s shareholders will receive $21.50 in cash for each share of Ruth\u2019s they own for a total equity value of approximately $715 million. The investigation concerns whether the Ruth\u2019s Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Darden is paying too little &hellip; Continue reading &quot;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-03T15:40:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)\",\"datePublished\":\"2023-05-03T15:40:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/\"},\"wordCount\":528,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/\",\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=\",\"datePublished\":\"2023-05-03T15:40:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., May 03, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Ruth\u2019s Inc. (Nasdaq \u2013 RUTH) Under the terms of the agreement, Ruth\u2019s will be acquired by Darden Restaurants, Inc. (\u201cDarden\u201d) (NYSE &#8211; DRI). Ruth\u2019s shareholders will receive $21.50 in cash for each share of Ruth\u2019s they own for a total equity value of approximately $715 million. The investigation concerns whether the Ruth\u2019s Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Darden is paying too little &hellip; Continue reading \"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-03T15:40:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)","datePublished":"2023-05-03T15:40:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/"},"wordCount":528,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/","name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=","datePublished":"2023-05-03T15:40:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTIwMyM1NTczMTMyIzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ruths-inc-nasdaq-ruth-magenta-therapeutics-inc-nasdaq-mgta-bellus-hea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth\u2019s Inc. (Nasdaq \u2013 RUTH), Magenta Therapeutics, Inc. (Nasdaq \u2013 MGTA), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=754395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=754395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=754395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=754395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}